VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $53,502,000 | -91.6% | 2,034,281 | -67.5% | 2.61% | -89.7% |
Q4 2015 | $635,549,000 | -36.1% | 6,252,331 | +12.1% | 25.22% | -20.2% |
Q3 2015 | $994,984,000 | -21.5% | 5,577,892 | -2.2% | 31.62% | -13.6% |
Q2 2015 | $1,267,034,000 | +8.5% | 5,703,510 | -3.0% | 36.58% | +2.7% |
Q1 2015 | $1,167,293,000 | +33.1% | 5,877,016 | -4.1% | 35.64% | +16.7% |
Q4 2014 | $876,779,000 | +1.5% | 6,126,609 | -7.0% | 30.53% | -4.7% |
Q3 2014 | $864,160,000 | +13.2% | 6,586,582 | +8.9% | 32.02% | +4.1% |
Q2 2014 | $763,082,000 | +3.5% | 6,050,442 | +8.2% | 30.78% | +3.3% |
Q1 2014 | $737,267,000 | +2.7% | 5,592,558 | -8.5% | 29.80% | +1.4% |
Q4 2013 | $717,693,000 | +4.6% | 6,113,227 | -7.0% | 29.38% | -4.5% |
Q3 2013 | $685,823,000 | +19.7% | 6,573,589 | -1.3% | 30.77% | +16.0% |
Q2 2013 | $573,073,000 | – | 6,657,451 | – | 26.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |